GPT and hemophilia B: In a Phase 1/2 clinical trial in 7 adult patients with severe hemophilia B, 2 patients developed elevated aspartate aminotransferase (AST) and alanine aminotransferase (ALT) levels, beginning 4 weeks after infusion of an AAV2 vector expressing FIX transgene [99].